source
- BMS ends Cellares pact over cell therapy production problems, triggering layoffsSetbacks to efforts to use Cellares’ automated platform to make an approved CAR-T cell therapy led BMS to terminate its partnership with the manufacturing specialist.BioSpace · 4h ago↗ source
- Biohaven could get up to $795M in epilepsy alliance with SK BioAt the center of Biohaven’s agreement with SK Biopharmaceutical is the ion channel platform and the lead epilepsy candidate opakalim, for which Phase 2/3 data are expected later this year.BioSpace · 4h ago↗ source
- Percutaneous Catheter Recall: Boston Scientific Removes ENROUTE Transcarotid Neuroprotection SystemENROUTE Transcarotid Neuroprotection Systems may have arterial sheath tip separation or partial tip separation during use.